Simvis S.A. is granted the control of Gerolymatos International’s property in 4 Asklipiou Street in Kryoneri, housing 13,400 m2 of buildings on a 27,000 m2 stretch of land. Simvis S.A. will place its initial attention on the utilization of its GMP-compliant Pharmaceutical Manufacturing Plant -an ex-GSK state-of-the-art plant licensed for the production of the following non-sterile human medical products and Medical Devices:
- Liquids for external use
- Liquids for internal use (syrups, suspensions, oral drops)
- Semisolids: creams, ointments, gels
- Tablets: plain and film coated
Simvis S.A. will focus so much so on the production of its shareholders’ products, as well as 3rd party contract manufacturing.
